PROTHENA CORP PUBLIC LTD CO business relationships

Companies named in PROTHENA CORP PUBLIC LTD CO’s 10-K filed 2026-02-27, and public companies whose annual reports name PROTHENA CORP PUBLIC LTD CO. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 5.4 / 10
AI naming: 70 / 100
Agent readiness: 30 / 100
AI adoption: 0 / 100

Named in PROTHENA CORP PUBLIC LTD CO’s annual report 7

Roche GroupCustomer7.7
“Revenue is recognized only when the Company satisfies an identified performance obligation by transferring a promised good or service to a customer (in th e Compan y's case, BMS and Roche).” SEC filing
Roche GroupLicensor7.7
“Our Collaboration Agreement with BMS and our License Agreement with Roche contained multiple performance obligations.” SEC filing
BRISTOL MYERS SQUIBB CO (BMY)Partner7.7
“Collaboration Agreement with Bristol Myers Squibb” SEC filing
Roche GroupPartner7.7
“Prasinezumab is the focus of our worldwide collaboration with Roche.” SEC filing
Roche GroupSupplier7.7
“We are dependent upon Roche with respect to further development of prasinezumab.” SEC filing
NOVO NORDISK A S (NVO)Partner6.7
“Hoffman-La Roche Ltd and Hoffmann-La Roche Inc. (together "Roche"), Bristol Myers Squibb Company ("BMS"), and Novo Nordisk, and amounts we may receive under such collaborations; the sufficiency of our cash position to fund advancement of a broad pipeline and completion of our ongoing clinical trials...” SEC filing
NOVO NORDISK A S (NVO)Supplier6.7
“We are dependent on Novo Nordisk, and its third-party manufacturers if applicable, to manufacture clinical supplies of coramitug.” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.